Dry Eye Syndrome Market Analysis

  • Report ID: 4587
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Dry Eye Syndrome Market Analysis

End-user (Hospitals, Eye Clinics)

The global dry eye syndrome market is segmented and analyzed for demand and supply by end user into hospitals, eye clinics, and others. Out of which, the eye clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the higher demand and greater number of eye clinics and optometrists present all around the world. Furthermore, eye clinics have the specialty in providing treatment for the eye disorders, that leads to better facilities and advanced technique adoption for the treatment of the diseases, and it is further expected to boost the segment’s growth in the market. In 2022, the United States have nearly 1000 eye surgery clinics. Moreover, in 123 countries, there are around 300,000 optometrists. Furthermore, according to the World Economic Forum, to meet the global needs, the world needs around 14 million optometrists.

Treatment (Nutritional Supplements, Surgery)

Moreover, the global dry eye syndrome market can be segmented by treatment into nutritional supplements, and surgery. Out of these, the nutritional supplements segment is expected to hold the largest share over the forecast period. This can be attributed to an upsurge in the intake of dietary supplements in the form of vitamin D and vitamin B12 that helps in providing relief from the symptoms such as inflammation and alleviating burning. In addition, mineral oils are also present in the eye drops that treat mild to moderate dry eye disorders, and it is predicted to surge the growth of the segment in the market.

Our in-depth analysis of the global market includes the following segments:

                  By Type

  • Evaporative
  •  Aqueous

                  By Diagnosis

  • Schirmer Test
  • Eye Exam

                  By End User

  • Hospital
  • Eye Clinics
  • Others

                  By Treatment

  • Nutritional Supplement
  • Surgery
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4587
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of dry eye syndrome is evaluated at USD 7.4 billion.

The dry eye syndrome market size was over USD 6.98 billion in 2024 and is anticipated to exceed USD 18.03 billion by the end of 2037, witnessing over 7.5% CAGR during the forecast period i.e., between 2025-2037. Surging count of people using contact lenses, and rising prevalence of dry eye syndrome will drive the market growth.

North America is expected to hold the largest industry share by 2037, backed by higher number of people suffering from dry eye disease in the region.

The major players in the market include Lumenis Be Ltd., Johnson & Johnson Services Inc., Alcon Vision LLC, Allergan (AbbVie), Novartis AG, Allostera Pharma Inc., I-Med Pharma Inc., Acadia Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample